(0.86%) 5 248.49 points
(1.22%) 39 760 points
(0.51%) 16 400 points
(1.25%) $82.37
(1.05%) $1.736
(0.75%) $2 229.30
(-0.19%) $24.71
(0.99%) $918.75
(0.14%) $0.925
(0.47%) $10.82
(-0.10%) $0.790
(0.39%) $92.80
5 days till quarter result
(bmo 2024-04-02)
Expected move: +/- 4.12%
Live Chart Being Loaded With Signals
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally...
Stats | |
---|---|
Today's Volume | 335.00 |
Average Volume | 13 145.00 |
Market Cap | 17.41M |
EPS | $0 ( 2024-03-21 ) |
Next earnings date | ( $0 ) 2024-04-02 |
Last Dividend | $0.0700 ( 2023-05-24 ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.41 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-22 | Mehalik Daniella | Buy | 70 000 | Stock Option (Right to Buy) |
2024-01-22 | Mehalik Daniella | Buy | 35 000 | Stock Option (Right to Buy) |
2023-11-27 | Mehalik Daniella | Sell | 0 | Common Stock, $.005 Par Value |
2023-09-21 | Shoemaker Shannon | Buy | 80 000 | Stock Option (Right to Buy) |
2023-09-21 | Shoemaker Shannon | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
93.99 |
Last 96 transactions |
Buy: 1 000 549 | Sell: 33 710 |
Psychemedics Corp Correlation
10 Most Positive Correlations | |
---|---|
HALL | 0.894 |
GSM | 0.876 |
ALTA | 0.873 |
NEXI | 0.862 |
OSMT | 0.861 |
MRUS | 0.86 |
XPER | 0.855 |
SNCR | 0.848 |
PAYO | 0.847 |
SRZN | 0.844 |
10 Most Negative Correlations | |
---|---|
CLDX | -0.902 |
BNIXU | -0.901 |
BLZE | -0.881 |
NUTX | -0.878 |
RDVT | -0.872 |
GLMD | -0.844 |
STIM | -0.843 |
BGNE | -0.843 |
COFS | -0.842 |
HALO | -0.842 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Psychemedics Corp Financials
Annual | 2022 |
Revenue: | $25.24M |
Gross Profit: | $9.29M (36.81 %) |
EPS: | $-0.190 |
Q3 | 2023 |
Revenue: | $5.70M |
Gross Profit: | $2.09M (36.66 %) |
EPS: | $-0.360 |
Q2 | 2023 |
Revenue: | $5.54M |
Gross Profit: | $2.06M (37.19 %) |
EPS: | $-0.130 |
Q1 | 2023 |
Revenue: | $5.86M |
Gross Profit: | $2.21M (37.63 %) |
EPS: | $-0.0700 |
Financial Reports:
No articles found.
Psychemedics Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0800 | 1997-01-13 |
Last Dividend | $0.0700 | 2023-05-24 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-08 | |
Next Payout Date | N/A | |
# dividends | 100 | -- |
Total Paid Out | $12.60 | -- |
Avg. Dividend % Per Year | 1.61% | -- |
Score | 2.9 | -- |
Div. Sustainability Score | 2.65 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.861 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $0.400 | 1.67% |
1998 | $0.440 | 1.87% |
1999 | $0.640 | 3.20% |
2000 | $0.640 | 3.56% |
2001 | $0.400 | 2.00% |
2002 | $0.240 | 1.46% |
2003 | $0.320 | 3.43% |
2004 | $0.320 | 3.37% |
2005 | $0.360 | 2.82% |
2006 | $0.475 | 3.39% |
2007 | $0.575 | 2.99% |
2008 | $0.660 | 4.13% |
2009 | $0.580 | 9.01% |
2010 | $0.480 | 6.08% |
2011 | $0.480 | 5.66% |
2012 | $0.600 | 6.49% |
2013 | $0.600 | 5.52% |
2014 | $0.600 | 4.14% |
2015 | $0.600 | 3.98% |
2016 | $0.600 | 6.17% |
2017 | $0.600 | 2.50% |
2018 | $0.690 | 3.33% |
2019 | $0.720 | 4.46% |
2020 | $0.180 | 2.00% |
2021 | $0.0500 | 0.97% |
2022 | $0.210 | 2.94% |
2023 | $0.140 | 2.84% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.171 | 1.500 | -3.42 | -5.13 | [0 - 0.5] |
returnOnAssetsTTM | -0.276 | 1.200 | -9.21 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.416 | 1.500 | -5.73 | -8.60 | [0.1 - 1] |
payoutRatioTTM | -0.307 | -1.000 | -3.07 | 3.07 | [0 - 1] |
currentRatioTTM | 1.462 | 0.800 | 7.69 | 6.15 | [1 - 3] |
quickRatioTTM | 1.179 | 0.800 | 7.77 | 6.22 | [0.8 - 2.5] |
cashRatioTTM | 0.254 | 1.500 | 9.70 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.187 | -1.500 | 6.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 3.43 | 1.000 | 9.84 | 9.84 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0431 | 2.00 | -0.0144 | -0.0287 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0702 | 2.00 | -0.0351 | -0.0702 | [0 - 20] |
debtEquityRatioTTM | 0.356 | -1.500 | 8.58 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.377 | 1.000 | 7.05 | 7.05 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.106 | 1.000 | -4.11 | -4.11 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.0938 | 1.000 | -1.632 | -1.632 | [0.2 - 2] |
assetTurnoverTTM | 1.617 | 0.800 | 2.55 | 2.04 | [0.5 - 2] |
Total Score | 2.65 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -4.43 | 1.000 | -0.549 | 0 | [1 - 100] |
returnOnEquityTTM | -0.416 | 2.50 | -3.68 | -8.60 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0702 | 2.00 | -0.0234 | -0.0702 | [0 - 30] |
dividendYielPercentageTTM | 4.67 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0431 | 2.00 | -0.0144 | -0.0287 | [0 - 30] |
payoutRatioTTM | -0.307 | 1.500 | -3.07 | 3.07 | [0 - 1] |
pegRatioTTM | 0.297 | 1.500 | -1.354 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0109 | 1.000 | -2.77 | 0 | [0.1 - 0.5] |
Total Score | -0.925 |
Psychemedics Corp
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators